The Big Health Care Conundrum: How To Sustainably Unlock The Value Of Diagnostics
Novo holdings panel asks diagnostics industry leaders how to keep the focus on testing post-pandemic
How can stakeholders capitalize on this moment of acute public awareness of diagnostics to improve adoption of tests and screening in the long term? At a recent roundtable event, the CEOs of Roche Diagnostics, GE Healthcare, Labcorp and Synlab, among others, gave their thoughts on how the system must change.
You may also be interested in...
The Swiss company is preparing for a smooth transition in 2023, appointing 20-year Roche veteran and diagnostic chief Thomas Schinecker as its next chief executive as Severin Schwan becomes chairman.
Another key stage has been reached in Switzerland’s bid to enable US FDA-approved medtech to be used in the local population.
Digitization of the German health care system has been slow to get going, as the health ministry readily admits. A fresh start should bring different results, the ministry’s head of e-health Sebastian Zilch told Medica attendees.